April 17, 2025

Phase 3 Trial Supports New Gonorrhea Drug

Trial shows oral gepotidacin is non-inferior to ceftriaxone plus azithromycin for treating uncomplicated urogenital gonorrhea.

Conexiant

April 17, 2025

Climate Identified as Key Virus Driver

Researchers found Oropouche virus to be underreported during a large-scale study across Latin America, with climate emerging as the primary driver of transmission risk.

Conexiant

April 17, 2025

Eyebrows Signal Understanding Gaps in Conversation

Eyebrow furrows can silently signal 'I've not received enough information,' researchers found, as these facial cues influenced the likelihood and type of verbal repair in conversation.

Conexiant

April 16, 2025

Triple Drug Combo May Halt Enterovirus Infections

All three components have previously completed clinical trials for other applications and established safety profiles in humans.

Conexiant

April 16, 2025

E-Cigs + Cigarettes: Worse Disease Odds

"There is a need to reassess the assumption that e-cigarette use provides substantial harm reduction across all cigarette-caused diseases, particularly accounting for dual use," warns a comprehensive meta-analysis.

Conexiant

April 15, 2025

Link Between CT Scans and Future Cancer Incidence?

At current use and radiation dose levels, CT scans may eventually account for 5% of all cancers annually, according to a recent modeling study. The danger is greatest for infants, followed by children...

The ASCO Post

April 15, 2025

ACIP to Weigh COVID, RSV, Measles Shots

The CDC's expert panel convenes to discuss next-gen COVID-19 shots and vaccination guidelines for various diseases amid a US measles outbreak.

Reuters

April 15, 2025

Preferred Lip Size Differs by Gender

"Lip plumping will mostly appeal to women rather than men (who prefer thinner lips)," finds new research showing how lip size manipulations influence perceived facial attractiveness.

Conexiant

April 15, 2025

Pediatric ALL or Lymphoblastic Lymphoma: Reduced Induction Dexamethasone and High-Dose Methotrexate

UK investigators found that a shorter duration of induction dexamethasone did not reduce steroid-related toxicity, and high-dose methotrexate did not reduce CNS relapse among patients younger than age...

The ASCO Post